TEMPO.CO, Jakarta - The government has kicked off the first stage of the Covid-19 vaccination program, prioritizing health workers, state officials and public figures. Indonesia uses the Sinovac, which has an efficacy level of 65.3 percent for people aged 18 to 59 years.
Tolhas Banjarnahor, a specialist in internal medicine from Primaya Hospital Tangerang, said that Sinovac uses a part of the dead SARS Cov-2 virus. Once injected, they will stimulate the body's immune system to form antibodies against the virus.
With vaccination, a person can avoid viral infection or at least experience only mild symptoms.
Nevertheless, there were nine groups that were not recommended to receive the vaccination.
- People with a history of allergies to vaccines or ingredients in the vaccine, and someone than can suffer severe allergic reactions to the vaccine.
- People with a history of uncontrolled blood clotting.
- People with chronic disorders or diseases, such as severe heart problems, uncontrolled hypertension, uncontrolled diabetes mellitus, severe kidney disease, liver disease, tumors, and other uncontrolled chronic diseases.
- People with a history of immune system disorders or having had therapy that compromises the immune system in the last four weeks.
- People with a history of epilepsy or neurological disorders.
- Pregnant women and breastfeeding mothers.
- People who have been infected with Covid-19.
- Specifically for the Sinovac vaccine, people over 59 years of age and under 18 years of age.
- Specifically for Moderna and Pfizer vaccines, people under 16 years of age.
Those who had taken the Covid-19 vaccines are still advised to follow health protocols until the pandemic is officially over, including wearing face masks, avoiding crowds, and washing their hands regularly.